SCHEMBL3132334

SCHEMBL3132334

O=C1C(=Cc2ccc(-c3ccccc3)o2)SC(=S)N1Cc1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.73
ALDH1A1 P00352 4/20 0.73
MEN1 O00255 4/20 0.73
KMT2A Q03164 4/20 0.73
RECQL P46063 3/20 0.73
LMNA P02545 3/20 0.73
MCL1 Q07820 2/20 0.73
ALOX12 P18054 2/20 0.73
ENPP2 Q13822 1/20 0.72
POLB P06746 4/20 0.72
TDP1 Q9NUW8 2/20 0.72
EIF4E P06730 1/20 0.72
EIF4G1 Q04637 1/20 0.72
THRB P10828 1/20 0.72
NPSR1 Q6W5P4 1/20 0.72
RAB9A P51151 1/20 0.67
SYK P43405 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
EP300 Q09472 1/20 0.66
CREBBP Q92793 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3132319 1.00 MAPT (0.73) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL3132328 1.00 MAPT (0.73) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL19021494 0.92 MEN1 (0.73) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL22240435 0.92 MEN1 (0.68) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL23145046 0.91 STAT3 (0.76) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL46211 0.91 STAT3 (0.76) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL18301010 0.91 STAT3 (0.76) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL6092742 0.90 MEN1 (0.66) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL8594643 0.90 MEN1 (0.71) MAPTALDH1A1MEN1KMT2ARECQL
SCHEMBL4408844 0.90 EP300 (0.82) MAPTALDH1A1MEN1KMT2ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 US disclosed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 MAPT 3126/4885ALDH1A1 1264/4885MEN1 4512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.